Extracellular vesicles (EVs), including exosomes, play a key role in inter and intracellular communication, promoting the proliferation and invasion of recipient cells to support tumor growth and metastasis. Metastasis comprises multiple steps that first include the detachment of tumor cells through epithelial to mesenchymal transition (EMT), allowing the physical dissemination to distant organs. Thereafter, cancer-derived exosomes are still critical components for preparing the tumor microenvironment by (i) enabling tumor cells to escape from the immunological surveillance and (ii) arranging the pre-metastatic site for the engraftment of detached cancer cells. In this review, we discuss the multifaceted role of EVs in the multiple steps of metastasis. Future research directions draw attention to EVs as biological targets for cancer diagnosis, prognosis and therapy. However, due to their significant role in cell communication, they may become a valuable drug delivery system.
Epithelial-mesenchymal transition (EMT) is a hallmark of cancer progression and metastasis. Accumulating evidence indicates that extracellular vesicles, especially exosomes, play an important role in this process. 1 Exosomes have been associated with the initiation, development and prognosis of different types of cancer including pancreatic, 2 lung, 3 breast 4 and prostate cancer. 5 These extracellular vesicles (EVs) are capable of transferring oncogenic proteins and nucleic acids that modulate the activity of recipient cells and play decisive roles in tumorigenesis, growth, progression, drug resistance and metastasis. [6] [7] [8] [9] [10] [11] Metastases are responsible for approximately 90% of all cancer-related deaths. Although the death rate is elevated, metastasis is a poorly understood phenomenon of cancer pathogenesis. 12 The establishment of a metastatic niche requires a complete series of distinct steps, which include invasion through the basement membrane, extravasation into the bloodstream, dissemination through circulation to the distal tissue parenchyma, and adaptation to the new microenvironment. 13, 14 The EMT must occur prior to physical dissemination of cancer cells to distant organs by which epithelial cells acquire mesenchymal characteristics showing reduced intercellular adhesion and increased motility, 15 endowing the incipient cancer cells with invasive and metastatic properties, 16 a key event for tumor progression. However, the EMT switch may not be sufficient to describe all types of migratory phenotypes observed within carcinoma cells, but may represent one subtype of invasive behavior important for metastasis. The EMT complex may be influenced by different pathways and has many potential mechanisms of regulation by miRNA that can influence multiple steps in cancer cell metastasis; miRNAs are well-established as key regulators of the EMT program in epithelial cells. 17 The exosomes from tumor cells contain oncogenic proteins and microRNAs that may affect the transcription and/or translation of new proteins in target cells. 18 Although EMT enables the physical dissemination of cancer cells to distant organs, the disseminated tumor cells need a conducive microenvironment to spread, mature and metastasize. In the "Seed and Soil" hypothesis, the tumor cell is a seed seeking the most fertile soil (distant organ) for its growth. 19, 20 In this sense, tumor cells release exosomes ("seeds") that travel to distant organs ("soil") and release growth factors ("fertilizers") to acclimate the "foreign soil" and prepare the metastatic niche. 21 In this context, some questions may arise. Would these extracellular vesicles or exosomes play any role in EMT? Which components are present inside these extracellular vesicles? Is it possible that these extracellular vesicles prepare the pre-metastatic niche? These questions are the major points of this review, which will be explored.
Tumor and Stromal Cell Interaction: A Two-Way Handshake through Exosomes
For many years, work in cell and biological development has demonstrated that the cell function depends on the context and architecture. The interactions between the cell and the microenvironment have shown that the substrate may affect cellular morphology and specific cell functions. Cancer is a complex biological disorder whose behavior is influenced by the specificity and context of the tissue architecture, including the interactions with ECM. 22 ECM has intrinsic interactions with cells, being capable of inducing functional gene expression, which may alter the regulation of mRNA processing, translation, post-translational modifications, extracellular organization and secretion. 23 The stroma, the connective tissue network of an organ, could be influenced by EVs secreted by tumor cells, establishing a crosstalk between cancer and stromal cells. 24 Stromal fibroblasts are modulated by tumor-derived exosomes containing transforming growth factor-beta (TGF-b). Cancer exosomes express a functional TGF-b that drives the differentiation of fibroblasts to a myofibroblast-like phenotype, creating a microenvironment that supports tumor growth, vascularization and metastasis through the production of growth factors, proteases and extracellular matrix proteins. 25 Similarly, stroma-derived exosomes promote protrusive activity, motility and metastasis of breast cancer cells via the activation of autocrine Wnt-planar cell polarity (Wnt-PCP) signaling. 26 It was shown that human breast cancer cells internalized fibroblast-derived exosomes and repackaged the exosome cargo with endogenous Wnt11, resulting in the activation of autocrine Wnt-PCP signaling. This intriguing finding suggests that exosomes act as crosstalk agents between cancer and stromal cells (Fig. 1c) . Its seems that miRNAs mostly influence metastasis-related pathways, such as angiogenesis promoting genes, adhesion molecules, cell cycle proteins and proteases. Breast cancer cell-derived exosomes also contain precursor miRNAs that can be processed to mature microRNAs within cancer exosomes and induce a rapid and efficient silencing of mRNAs in non-tumorigenic epithelial cells, resulting in transcriptome reprogramming and oncogenic transformation. 27 MMPs modulate the extracellular matrix during several cellular events that include invasion and migration. Many studies have shown that MMPs promote the degradation of nearly all structural components of the ECM in the physiological or pathological process, including the earliest stages of cancer development and progression. 28 The influence of exosomes in the microenvironment was also related to their capacity to regulate pericellular proteolysis through MMPs secretion. 29 This is corroborated by the evidence that MMP-13, a metalloproteinase involved in angiogenesis and extracellular matrix degradation, was frequently related to an increased risk of metastasis [30] [31] [32] and was identified as one of the exosomes'; cargo components capable of inducing the migration and invasion of cancer cells. Nasopharyngeal cancer (NPC) cells released exosomes containing MMP-13 in the patient's plasma, which facilitated the migration and invasion of NPC cells in a Transwell assay system. 33 These authors further demonstrated in vitro that silencing of MMP-13 synthesis by siRNA inhibited the effect of MMP-13 containing exosomes in cell metastasis and angiogenesis. Tumor cells also secrete exosomes containing membrane type 1 matrix metalloproteinase (MT-1 MMP) that activates pro-MMP-2 in the degradation of type 1 collagen, 34 which may be involved in pathological ECM remodeling and cell signaling networks involved in invasion.
The nature of exosome interactions with stromal cells was demonstrated by exosome labeling experiments, which showed that melanoma exosomes interact and influence endothelial cell morphology through these extracellular vesicles. 35 Additionally, orthotopic breast cancer secreted green fluorescent protein (GFP) labeled exosomes after 10 days of induction in nude mice. After six weeks, these cells metastasized to lungs, where they secreted GFP-exosomes into the microenvironment. The main target of the GFPexosomes was cancer cells associated fibroblasts and other stromal cells, which may be involved in metastatic niche formation, suggesting that tumor migratory cells also change the metastatic niche using EV contents. 36 An elegant work using Cre-LoxP system identified the uptake of tumor cell-derived extracellular vesicles by less malignant tumor cells within the same tumor and within distant tumors. These EVs change the phenotype of these cells to a migratory behavior. Probably, the components involved in this phenomenon are mRNAs carried by EVs. 37 Similar investigations demonstrated angiogenesis promoting effect in lung cancer ascites induced by exosomes released from renal cells and primed sentinel lymph node metastasis by exosomes released from melanoma cells. 38, 39 Tumor-derived exosomes can educate stromal cells to behave as tumor-associated cells, supporting tumor growth and progression. For example, in vitro assays demonstrated that exosomes derived from gastric cancer cell line can activate macrophages through NF-jB activity, generating tumorassociated macrophages that produce IL-6, CCL12 and TNFa. 40 Additionally, exosomes obtained from melanoma patients could direct monocyte differentiation to tumorassociated DCs with a profile similar to a MDSC (myeloidderived suppressor cell) in vitro with IL-6, TNF-a and TGFb secretion. 41 Lung cancer cell line-derived exosomes can induce a pro-inflammatory profile on mesenchymal stem cells (MSCs) via TLR2 activation by exosome membranebound HSP70, activating NF-jB activity that leads to the production and secretion of IL-6, IL-8 and MCP-1 in vitro.
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Breast cancer-derived exosomes can induce MSCs to a myofibroblast-like phenotype through TGF-b pathway, leading to secretion of SDF-1, VEGF, CCL5 and TGF-b in vitro. 43 Similar to the observed phenomenon under physiological conditions, exosomes in this context exert a role in amplifying the tumor survival signals, modifying the behavior of stromal cells to support a pro-tumoral niche. It is noteworthy that tumor-derived exosomes can elicit distant stroma modification as an important step in the establishment of a metastatic niche (Fig. 2) . Although the role of stromal-derived extracellular vesicles in this process is still uncertain, as previously shown, they can alter the tumor environment and may participate in forming a distant metastatic niche to promote metastasis.
Epithelial-Mesenchymal Transition Induced by Cancer Cell Exosomes
EMT is a dynamic process that endows epithelial cells with high migratory capacity, a typical characteristic of the mesenchymal cells, in which many genes involved in cell adhesion, mesenchymal differentiation, cell migration and invasion are transcriptionally altered. 44 The changes in gene expression that contribute to the repression of the epithelial phenotype and activation of the mesenchymal phenotype involve overexpression of master regulators that include SNAIL, SLUG, TWIST1, TWIST2 and the zinc-finger E-box-binding (ZEB) transcription factors ZEB1 and ZEB2. [17] [18] [19] [20] 45 In several carcinomas, EMT-inducing signals are provided by TGF-b, 21 epidermal growth factor (EGF), 46 hepatocyte growth factor (HGF), 47 platelet-derived growth factor (PDGF) 48 and insulin-like growth factor (IGF). 49 These factors are commonly produced by mesenchymal stem cells (MSCs) present in the tissue and often found inside extracellular vesicles. 50 As an example, TGF-b inside EVs (probably released by cancer cells), but not soluble TGF-b, induces the polarization of MSCs to a tumor-associated myofibroblast (TAM) phenotype, secreting several growth and anti-inflammatory factors as aforementioned. 43, 51, 52 Recently, EVs, including exosomes, have emerged as another important mechanism in signaling during EMT and tumor progression. Bladder cancer exosomes can induce EMT in urothelial cells, confirmed by the expression of several mesenchymal markers in urothelial cells, including asmooth muscle actin (a-SMA), S100 calcium binding protein A4 (S100A4) and SNAIL. Their epithelial markers, Ecadherin and b-catenin, were decreased with subsequent increase in migratory and invasive phenotype. 53 A further study evaluated the occurrence of EMT in a nontumorigenic breast epithelial cell line after treatment with EVs derived from a highly invasive breast cancer cell line and showed that MDA-MB-231 breast cancer cells treated with linoleic acid release EVs that could induce EMT in nontumorigenic human mammary epithelial cells (MCF-10A), confirmed by downregulation of E-cadherin expression and upregulation of mesenchymal markers such as SNAIL1, SNAIL2, TWIST1 and 2, SIP1, vimentin and N-cadherin. 54 The MCF-10A cells treated with EVs secreted MMP-2 and MMP-9, enzymes capable of degrading the extracellular matrix, an important event for the initiation of migration and invasion. 54 Although previous studies have shown that cancer-derived exosomes may contribute to the epithelial-mesenchymal transition (EMT) in untransformed cells, few studies have defined the exosome cargo upon EMT induction. Now, researchers are trying to understand which molecules are involved in this process. In this sense, recent work has determined that exosomes of NPC cells infected with Epstein-Barr virus (EBV) contain endogenous hypoxia-inducible factor-1a (HIF1a), a key pro-metastatic transcriptional factor that mediates numerous key aspects of tumor development and progression in recipient cells. Additionally, these exosomes can change the expression of mesenchymal markers in recipient cells, such as an increase of E-cadherin and decrease of N-cadherin. 55 Another study has identified a miRNA (Let-7i) modulator of exosome-mediated EMT in melanoma cells and defined two other miRNA modulators of EMT in serum exosomes of patients with melanoma (miR-191 and let-7a). 56 Yet, the molecular characterization of NPC-derived exosome cargo revealed appreciable levels of MMP-13, which is involved EMT processes. 33, 57 Of note, tumor exosomes released under hypoxic conditions exhibit enrichment of potent EMT-transducing signaling molecules, such as TGF-b, MMPs, tumor necrosis factor alpha (TNF-a), caveolin-1, PDGFs and b-catenin, compared with exosomes secreted under normoxic condition. 58, 59 Several studies demonstrated the cellular properties (epithelial or mesenchymal) that present a metastatic phenotype influences the cargo of secreted EVs. Cells that present a metastatic phenotype or undergo EMT secrete EVs with several proteins linked to EMT. 60 Proteomic analysis revealed that human squamous cell carcinoma cells (A431) undergo an EMT-like state through inhibition of E-cadherin and EGFR stimulation associated with upregulation of 32 proteins such myosin-Ib (MYO1B), extracellular matrix protein 1 (ECM1), integrin beta-1 (ITGB1), integrin alpha-2 (ITGA2), desmoglein-3 (DSG3) and laminin subunit gamma-2 (LAMC2). Of note, bioinformatics analysis showed that A431 cells undergoing the EMT process oversecrete proteins involved in cellular growth, cell-to-cell signaling, cell movement and cell morphology, which is consistent with processes involved in tumor invasion and metastasis. 60 Cells that undergo a metastatic phenotype release different exosome contents compared to non-metastatic phenotypes. There are proteomic differences between a human bladder carcinoma cell line without metastatic capacity (T24) and its two isogenic derivative cell lines (SLT4 and FL3), which form metastases in the lung and liver of mice. Several proteins were linked to EMT, including increased abundance of vimentin and hepatoma-derived growth factor (HDGF) in the membrane, and casein kinase II (CK2) and annexin A2 in the lumen of exosomes from metastatic cells. 61 Bioinformatics analysis of regulated proteins showed an association with cellular movement and cell-to-cell signaling, which is in agreement with the properties of metastatic cells. 61 A similar study compared the exosome protein profile of primary (SW480) and metastatic (SW620) human isogenic colorectal cancer cell lines. A major finding was the selective enrichment of metastatic factors (MET, S100A8, S100A9, TNC) and signal transduction molecules (EFNB2, EGFR, JAG1, SRC, TNIK) in exosomes derived from metastatic
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SW620 cells, which follows observations in various EMT models. 62 Madin-Darby canine kidney (MDCK) cells transformed with oncogenic H-Ras release exosomes enriched with mesenchymal markers compared to non-transformed cells. These markers are vimentin, several proteinases (e.g., MMP-1, 214, 219 and ADAM-10), integrins (e.g., ITGB1, ITGA3 and ITGA6), EMT-related transcription factors (e.g., YBX1) and core splicing complex components (e.g., SF3B1, SF3B3 and SFRS1). 63 Therefore, exosomes appear as a class of secreted nanoparticles, presenting protein and lipid on their surface, and capable of carrying RNA and proteins. Moreover, because their contents are altered in cancer and they are important mediators of intercellular communication and regulators of the cellular niche, they are emerging as a potential novel class of therapeutic targets and natural drug delivery systems. [64] [65] [66] In fact, plasma exosomes can effectively deliver siRNA to monocytes and lymphocytes, causing selective gene silencing. 67 Similar studies showed that exosomes loaded with siRNA against RAD51 and RAD52 or miR-146b can be taken up by cancer cells, resulting in cancer cell death. 68, 69 Furthermore, exosomes can deliver chemotherapeutics such as doxorubicin specifically to tumor tissue, leading to inhibition of growth of breast adenocarcinoma xenograft tumors in vivo, without overt toxicity. 70 Additionally, anti-inflammatory agents, such as cucurbitacin I, a STAT3 inhibitor loaded into exosomes produced therapeutic effects in brain inflammatory-related diseases, such as glioblastoma. 71 These publications and others underscore the relevance of exosomebased drug delivery system.
Regarding personalized therapy, EVs collected from one individual can be enriched, loaded with drugs and/or miRNAs, and given back to the same individual, without causing immunity-related issues. [72] [73] [74] Taken together, the findings suggest that transformed cells release several factors that may induce EMT in either normal or transformed epithelial cells, enhancing the progression of tumors. However, the EMT may be affected by the microenvironment that includes different lipids and extracellular matrix-associated proteins, and their influence on metastatic niche formation in different organs and sites may also depend on variations in the cargo components, suggesting that future therapeutic approaches may consider specific phenotypes of EVs, leading to a personalized treatment. A scheme of the overall process is depicted in Figure 1a .
Granting Tumor Cell Passage by Immunomodulation of Primary Niches
Exosomes have an important role in the physiopathological immune response. In vitro and in vivo assays demonstrated that exosomes released by innate immune cells, [75] [76] [77] [78] [79] [80] stromal cells 81, 82 and adaptive immune cells [83] [84] [85] are critical during inflammation by expanding the pro-inflammatory response, activating other immune cells. 75, 76, 78, 80, 82, 85 Additionally, they have an important role in the progression of the inflammatory response to resolution, 78 immune tolerance 77, 79 and immunomodulation. 83, 84 In summary, exosomes have a critical role in amplifying the signal emitted by the source cells in the immune response. The final effect will also depend on individual target cells. Their role is critical in the cancer immune response by triggering an efficient response against cancer. 86, 87 However, several tumors can overcome the immune response by immunomodulation. For example, selective depletion of CD41 T cells is one mechanism for the peripheral tolerance observed in breast cancer patients after highdose chemotherapy and peripheral blood stem cell transplantation, 88 suggesting that immune dysfunction may be a possible mechanism triggered by exosomes. However, how does the tumor exert a systemic immunomodulation? These results suggested that elements produced by tumor cells are responsible. Subsequent findings pointed to the exosomes as the effectors.
Although the physiopathological role of exosome in the immune response is beginning to be understood, is the exact mode of action in tumor immunomodulation is unknown. As previously mentioned, during EMT, several epithelial markers are lost, making possible cell detachment, invasion and migration. However, this event is prevented and inhibited by the immune system, mainly by T-lymphocytes (adaptive immune response) and NK (natural killer) cells (innate immune response). 89 Under normal conditions, detachment of epithelial cells is prevented by E-cadherin-mediated inflammatory inhibition via KLRG1, an important inhibitory receptor expressed on NK cells and a subset of CD4 1 and CD8 1 T cells, in which E-cadherin exerts a heterophilic interaction with KLRG1 and prevents the cytolytic effect of these cells. When E-cadherin inhibition of KLRG1 during EMT is lost, these cells destroy E-cadherin-negative cells, preventing the generation of metastatic cells. [90] [91] [92] [93] [94] However, this phenomenon is overcome by tumor cells, and exosomes have an important role in immunomodulation. This process can be dissected beginning with the innate and adaptive immunomodulation.
Exosomes play an important role in innate immunomodulation. In a murine model, pre-treatment with tumor-derived exosomes boosted the growth of the tumor graft by selectively suppressing NK cells in vivo. 92 Other studies demonstrated important mechanisms by which exosomes exert immunomodulation of the innate immune response. Two studies demonstrated that exosomes derived from different cancer patients and cell lines downregulated the expression of NKG2D in NK cells in vitro. 95, 96 In contrast, the activation of NKG2D can overcome the inhibitory self-recognition signaling by NK cells, leading to a cytotoxic effect, important for effective tumor response, 97 mainly by TGF-b in tumor-derived exosomes from a cell line derived from mesothelioma patients. 98 Additionally, exosomes from advanced melanoma patients could direct the differentiation of monocytes to a tumorassociated DC with a profile that suppresses the activity of activated T cells through TGF-b production. 41 These findings show the important role of exosome in innate immunomodulation, mainly by the suppression of cells involved with the cytolytic response.
Exosomes from tumor-associated cells also have a role in the immunomodulation of the tumor innate immune response. It was observed that DCs from melanoma patients produce exosomes with NKG2D ligand MICA/B, not ULBP-1, 87 and that high levels of circulating MICA/B were correlated with decreased NKG2D in immune cells. 99 Bone marrowderived MSCs educated with melanoma or lymphomaderived exosomes led them to produce several chemokines involved with macrophage recruitment (CCL2 and CCL7) in an in vivo model. 100 These findings show that tumor-derived exosomes promote immunomodulation indirectly by educating other immune cells to an immunosuppressive profile.
Exosomes also exert an important role in adaptive and systemic immunomodulation. One study observed that exosomes derived from breast cancer and mesothelioma cell lines downregulated the number of NKG2D-expressing CD8
1 T cells, inhibited the cytotoxic effects of CD8 1 T cells, and downregulated the expression of NKG2D in peripheral blood cells in vitro. 95, 96, 101 Interestingly, circulating FasL 1 microvesicles (60 to 100 nm) were detected in patients with oral squamous cell carcinoma, which induced apoptosis of activated T lymphocytes in culture. 102 These findings may also be correlated with the fact that T cells found at tumor sites and in the peripheral circulation of patients with cancer show a high rate of spontaneous apoptosis and signaling abnormalities. 102 Similar findings have also shown that exosomes from ovarian cancer patients, melanoma cell line and prostate cancer cell line induce apoptosis of T lymphocytes via FasL/Fas receptor in vitro. [102] [103] [104] In addition to CD4 1 T cell depletion, in vitro assays demonstrated that exosomes derived from breast cancer and ovarian cancer cell lines also inhibit CD8 1 T cell proliferation and promote T reg differentiation and expansion, converting CD4 1 T cells into T reg cells with upregulated expression of FasL, IL-10, TGFb1, CTLA-4 (cytotoxic T-lymphocyte antigen 4), GrB (granzyme B) and perforin under the control of exosomal TGFb. 105, 106 These findings show that tumor-derived exosomes harbor an immunosuppressive potential, leading to apoptosis of adaptive immune cells and the production of T reg cells.
One study observed a link between innate response and adaptive immunomodulation exerted by tumor-derived exosomes. In vitro assays demonstrated that lung cancer biopsyderived exosomes could donate EGFR to peripheral mononuclear cell-derived DCs and trigger a tolerogenic profile via EGFR/PI3K pathway, inducing the production of specific effector T reg cells. 107 These interesting findings demonstrate that, at least under some conditions, tumor-derived exosomes induce immunomodulation indirectly through innate cells.
In summary, studies have demonstrated that tumorderived exosomes cause a direct and indirect immunomodulation by suppressing, or even killing, the effector cells in the tumor-suppressive response (NK and CD8 1 T cells) and educate innate cells to a tolerogenic profile. Tumor-derived exosomes can directly or indirectly prime the tumor niche immune response by depleting effector CD4 1 T cells or polarizing a Treg response. Altogether, cancer exosomes have an important immunomodulation role in the primary niche, which favors tumor growth by suppressing the immune system response, leading to evasion of pre-metastatic and metastatic cells, supporting metastasis (Figs. 1b and 1c) . Notably, far from being restricted to local activity, the systemic immunomodulatory effect is a prerequisite for tumor cell dissemination and invasion, but the metastatic niche depends on the exosomes'; cargo components and their origin.
Establishment of the Metastatic Niche
Until recently, cancer research had focused on the biology and pathogenesis of primary tumors. 108 However, the main cause of cancer death is the progression to metastasis. Now, researchers are beginning to understand how cancer cells escape from the primary site, travel throughout the body, and select a new distant site to grow out as a secondary tumor.
Steven Paget's defined the term "Seed and Soil," a hypothesis for metastasis considered a hallmark in the study of this malignant disease, introducing the concept that a receptive microenvironment is required for the development of malignant tumors in distant tissues from metastasis. He noted that the "soil" or local tissue microenvironment must be conducive for disseminated tumor cells to "seed," promoting the development of metastases in these sites. 109 Paget's hypothesis was later confirmed by Fidler and colleagues, who demonstrated that cancer cells derived from a certain metastatic site exhibited enhanced abilities to metastasize to that specific organ, providing support for Paget's organ-specific metastasis theory. 110 It was demonstrated that tumor cells reached the vasculature of multiple organs, and despite this, development of metastasis occurred selectively in certain organs, but not in others. 110, 111 Clinical observations highlight that different cancers exhibit characteristic preferential sites for secondary metastases, dependent on the origin of the primary tumor, a phenomenon termed organ tropism. 112 These findings are consistently found in cancer patients, as exemplified by breast cancer metastasis, which shows preferential tropism to the lungs, liver and bones. 12 It is now well accepted that in addition to the intrinsic properties of metastatic cells, the microenvironment of the metastatic niche is critical to determining whether these disseminated tumors cells (DTCs) survive, remain dormant, or form macrometastases. 113 The microenvironment of then metastatic niche can then differ in different organs where metastases forms. 114 Recent findings provide evidence that the metastatic site can also be remotely primed to be permissive to engraftment of DTCs, even prior to the arrival of any tumor cells, supporting the concept referred to as premetastatic niche. 113, 115 Mini Review dos Anjos Pultz et al.
Although the investigation of the changes required in the microenvironment for DTC engraftment is a recent, undeveloped field of research, central functional elements have emerged. These include a perivascular location, modification of the ECM, remodeling of the vasculature, recruitment of bone marrow-derived cells (BMDCs), hypoxia and the expression of a variety of signaling molecules. Nontransformed cells, such as endothelial cells and fibroblasts, are pre-requirements and play an important role. 116 Tumor cells do not solely dictate their own fate, but the formation of a hospitable microenvironment is essential to enable the dissemination of tumor cells to spawn a secondary tumor growth. [117] [118] [119] Recently, the requirements for pre-metastatic niche formation have also incorporated the notion that its microenvironment depends on tumor-derived exosomes 2, 38, 117 (Fig. 2) .
Exosomes: Priming the "Soil" for Metastatic Cell "Seed"
Several publications indicate the important role of EVs in the preparation of the pre-metastatic niche and establishment of the tumor. There is information about the contents of exosomes and how they prepare the metastatic niche, which may act either by inducing chemokine receptor, changing the extracellular molecular adhesion, or creating an immunosuppressed microenvironment. Nude mice infused with a colorectal cancer cell line (HT-29) developed liver metastasis and have been used as metastasis model. In this case, the metastatic microenvironment presented a higher number of stromal cells expressing CXCR4 when nude mice were treated with HT-29 derived exosomes. 120 In contrast, inhibition of CXCR4 impaired the development of metastasis and the expression of this chemokine receptor, which was correlated with liver metastasis in patients with colorectal cancer. 121 In addition to the influence of exosomes on cell receptors, tumor-derived exosomes containing miR-105 have also been attributed to disrupt the vascular endothelial barriers during early breast pre-metastatic niche formation by targeting cellular tight junctions (as a key regulator of ZO-1). 122 Costa-Silva et al. showed that exosomes isolated from pancreatic ductal adenocarcinoma (PDAC) promote premetastatic niche formation in the mice liver, consequently enhancing the metastasis in this organ. When PDAC-derived exosomes were administered to mice prior to tumor cell injection, liver metastasis increased through TGF-b produced by Kupffer cells (KCs). 2 This cytokine acts like a "fertilizer" that enriches (prepare) the "soil" (organ or tissue) by promoting an immunosuppressive microenvironment, epithelialmesenchymal transition and angiogenesis. 123 Yet, injected PDAC cells were shown to co-localize around KCs. Examination of exosome-primed livers showed a substantial increase in extracellular fibronectin deposition, followed by an influx of bone marrow-derived macrophages (BMDMs). 2 The interactions between integrins and fibronectins are important for tumor cell establishment, providing adhesion, invasion and metastasis. In addition to promoting cell adhesion to the extracellular matrix, these interactions may also function in chemotaxis and control of proliferation. 124 Furthermore, an important work from Peinado et al. showed that exosomes from highly metastatic melanoma increased the metastatic behavior of primary tumors in a way distinct from that of tumor-derived growth factors, extracellular proteins and chemokines. These exosomes "educated" BMDCs via the MET receptor and recruited these cells through up-regulation of pro-inflammatory molecules at premetastatic sites to support tumor angiogenesis, invasion and metastasis. 125 Interestingly, exosomes not only prepare the premetastatic site for DTCs but also dictate the fate of these cells, mediating non-random patterns of metastasis. Hoshino et al. showed that exosomal integrins direct organ-specific colonization by fusing with target cells in a tissue-specific form, initiating pre-metastatic niche formation. They showed that integrins a6b4 and a6b1 specifically bound to lungresident fibroblasts and epithelial cells mediating lung tropism, while exosomal integrin avb5 specifically bound to Kupffer cells mediating liver metastasis. 126 Exosomal integrins not only promote adhesion but also trigger signaling pathways and inflammatory responses in target cells, resulting in the education of that organ to be permissive for the growth of metastatic cells, for example, through activating Src phosphorylation and pro-inflammatory S100 expression.
126

Conclusion and Perspectives
The complete picture of the functions of exosomes on cancer development and progression is yet to be revealed, although there is ample evidence that their structure and cargo components exert multiple modulatory activities. Cancer-derived exosomes can modify the tumor and its microenvironment, participating in every step involved from tumor initiation to metastasis. In this review, we highlighted their important roles in regulating EMT-related pathways, intercellular communication, immunomodulation of the primary tumor niche, tumor cell evasion and metastatic niche formation. We also stressed the notion that tumor-derived exosomes may act in preparation of the pre-metastatic niche for cancer metastasis, supporting a century-old hypothesis, known as the "seed and soil" hypothesis, for metastasis. A roadmap of the multifaceted roles, targets and cargos of exosomes is needed to understand their interactions with the environment, organs, tissues and immune cells, which will pave the way for developing novel diagnostic, prognostic and therapeutic approaches, leading to personalized cancer treatments and improved outcomes. Yet, due to its role in intercellular communication within the tumor microenvironment, exosomes may also emerge as promising systems of drug delivery.
